Fiona Ginty, PhD

Fiona Ginty, PhD leads a group of cellular and molecular scientists in Biosciences who are inventing new methods and applications for the life sciences industry, including new cell therapy workflows, forensics, synthetic biology and cell imaging. For over 10 years at GE Research, she has also led a multidisciplinary program and collaborations to develop a multiplexed imaging platform for fixed tissue, which has led to new insights into tumor biology and immune response. It has been commercialized by GE Healthcare as a service at Neogenomics Laboratory(MultiOmyx) and as a research platform (Cell DIVE). She is Principal Investigator on a NIH RO1 which is investigating apoptosis heterogeneity in colorectal cancer and co-PI with Indiana University which aims to characterize immune response to DCIS and patient outcomes. She has 13 patents and 32 publications that span nutrition, bone biology, metabolism, oncology and technology development and translation.